Blood Lymphocyte And Neutrophil Response Of Cultured Rainbow Trout, Oncorhynchus Mykiss, Administered Varying Dosages Of An Oral Immunomodulator – 'Fin-Immune™'
In a 10-week (May – August, 2008) Phase I trial, 840, 1+ rainbow trout, Oncorhynchus mykiss, received a commercial oral immunomodulator, Fin Immune™, at four different dosages (0, 10, 20 and 30 mg g-1) to evaluate immune response and growth. The overall objective of was to determine an optimal dosag...
Main Authors: | , |
---|---|
Format: | Text |
Language: | English |
Published: |
Zenodo
2009
|
Subjects: | |
Online Access: | https://dx.doi.org/10.5281/zenodo.1083286 https://zenodo.org/record/1083286 |